key: cord-0731890-7384i1w8
authors: Dov, Tschernin; Fruchtman, Yariv; Sergienko, Ruslan; David, Odeya; Leibovitz, Ron; Mazar, Julia; Leibovitz, Eugene
title: The Etiologic, Microbiologic, Clinical and Outcome Characteristics of Immunocompetent Young Children < 2 Years of Age Hospitalized with Acute Neutropenia
date: 2020-08-12
journal: Pediatr Neonatol
DOI: 10.1016/j.pedneo.2020.08.004
sha: deba9d017ec0144fa3294dd5cf91beb8e354fd0f
doc_id: 731890
cord_uid: 7384i1w8

Abstract Objectives To describe the etiologic, microbiologic, clinical and outcome characteristics of acute neutropenia (absolute neutrophil count, ANC, <1.5 × 109/L) in hospitalized immunocompetent children. Methods Serious bacterial infections (SBI) were defined as culture-positive blood, urine, cerebrospinal fluid, articular fluid or stool infections, alveolar pneumonia, Brucellosis and Rickettsiosis. Results 431/671 (64.2%) healthy infants and children hospitalized with acute neutropenia were <2 years of age; 176 (40.8%), 167 (38.8%) and 88 (20.4%) patients were aged 0–3, 4–12 and 13–24 months, respectively. There were 19 (4.4%), 53 (12.3%), 140 (32.5%) and 209 (50.8%) patients with ANC count <200, 200–500, 501–1000 and 1001–1500 × 109 cells/L, respectively. Severe neutropenia (<500 ×109/L) was recorded in 72 (16.7%) patients. Fever >380C was present in 208/431 (48.3%) patients. Blood cultures were positive in 10 (2.3%), with Brucella melitensis, Staphylococcus aureus and Enterobacter spp. identified in 4, 3 and 2 patients, respectively; 5/10 patients with positive blood cultures were < 3 months of age. Overall, 55/431 (12.7%) and 65/431 (15.1%) patients were diagnosed with SBIs and bacterial infections, respectively. Nasal washings-PCR for respiratory viruses was positive in 139/293 (47.4%) patients tested. An infectious etiology (bacterial and/or viral) was diagnosed in 190/431 (44.1%) patients. Three patients were diagnosed with acute lymphocytic leukemia. Resolution of neutropenia was achieved in 111/208 (53.4%) evaluable patients (63%, 50.6% and 48% of patients aged 0–3, 4–12 and >12 months, respectively and 56.8%, 53.5% and 52% of patients with severe, moderate and mild neutropenia, respectively). Conclusions Acute neutropenia is common in immunocompetent children < 2 years of age and is frequently associated with viral infections. We showed a substantial involvement of bacterial infections and particularly SBIs in the etiology of acute neutropenia. After a 1-month follow-up, resolution of neutropenia occurred in half of the patients, without association with age subgroups and with neutropenia severity.

Acute neutropenia occurring as a result of an infectious process is common in 74 immunocompetent infants and children and its differential diagnosis ranges between a severe Neutropenia was defined as an ANC < 1.5 × 10 9 /L. According to severity, neutropenia 175 was defined as severe (ANC < 0.5 × 10 9 /L), moderate (ANC between 0.5 and 1.0 × 10 9 /L) or 176 mild (ANC between 1.0 and 1.5 × 10 9 /L) 1,5 . Leukopenia was defined as a total WBC count of < 177 5.0 × 10 9 /L. Thrombocytopenia was defined as a platelet count of < 150.0 × 10 9 /L. Anemia was 178 defined as hemoglobin value > two standard deviations below the mean for reference population. 179

180

The following infections were considered SBIs for the purpose of the study: bacteremia, 182 bacterial meningitis, pneumonia, urinary tract infection, bacterial gastroenteritis, osteomyelitis 183 and septic arthritis 12-14 . All cases of pneumonia included were alveolar as this was considered 184

suggestive of a bacterial etiology. Brucellosis and Rickettsiosis, which are extremely common in 185 our geographic area, were also considered SBIs [15] [16] [17] For infants aged 1-2 months without a source of infection, the protocol for the initial 226 empiric treatment (following a complete or partial sepsis work-up) consisted of intravenous 227 ampicillin (50 mg/kg/day three times/day) plus gentamicin (5 mg/kg/day once/day). 228

Patients > 2 months of age with an ANC < 0.5 × 10 9 /L and without any source of 229 infection were treated empirically with intravenous ceftriaxone (50 mg/kg/day once/day) till 230 blood cultures results were available and afterwards the treatment was continued (or 231 discontinued) according to patients' general condition and resolution (or lack of resolution) of 232 neutropenia. 233

Every hospitalized patient was followed with at least one WBC count during the one-234 month period after discharge. 

Three patients were diagnosed with acute lymphocytic leukemia. Two of them were 330 febrile at admission, all three were leukopenic and none of them suffered from anemia or 331 thrombocytopenia. All three were examined at the emergency room due to an acute 332 disease/condition (vomiting, acute otitis media and upper respiratory infection, respectively). 333

One of these patients had RSV recovered from the nasopharyngeal wash, the second one had 334 nontypeable H. influenzae-acute otitis media and the third had adenovirus recovered from the 335 nasopharyngeal wash. Two suffered from mild neutropenia and the third from moderate 336 neutropenia (ANC 560 × 10 9 /L). The diagnosis of leukemia was made during hospitalization 337 following a bone marrow examination. 338

( J o u r n a l P r e -p r o o f

Data on the one-month follow-up after the resolution of neutropenia in the study patients 358

were available in 208 (48.2%) patients ( The purpose of this study was to continue and broaden our previously mentioned study 18 400 and describe the epidemiologic, etiologic, laboratory and short-time outcome characteristics of condition. During 2013-2015 we enrolled a considerable number of immunocompetent young 403 children < 2 years of age hospitalized with acute neutropenia in southern Israel and investigated 404 its infectious and non-infectious etiology, the patient distribution according to 3 age subgroups 405 (0-3, 4-12 and 13-24 months of age) and to severity of neutropenia and followed after the 406 resolution of neutropenia for a short time period after discharge. We considered that the broad 407 use of modern molecular technologies for the detection of viral pathogens during the last years 408 will enable us to reach more definitive etiologic diagnoses and determine in detail the relevant 409 responsible etiology of this condition in young children. 410

We found in the present study that infants and young children < The limitations of our study are mainly related to its retrospective nature, and it is 434 possible that some information on the enrolled patients was missed or incorrectly presented. 435

In addition, we cannot rule out the possibility that some of the patients enrolled in our study 436 might have suffered from congenital or from ethnical neutropenia which had not been previously 437 diagnosed 2 ̶ 4, 28, 29 . Another limitation is related to lack of follow-up data for a considerable 438 number of patients enrolled in the study and, as mentioned, the lack of a longer follow-up period 439

with repeated WBC counts after discharge from hospital. 440

In conclusion, in this study we described the infectious and non-infectious etiology of 441 acute neutropenia in immunocompetent infants and young children < 2 years of age and reported 442 that this condition is common in this age group. We established that viral etiology is frequently 443 associated with this condition and characterized the main viruses associated with acute 444 neutropenia. We reported on the involvement of bacterial infections in the etiology of acute 445 neutropenia in this age group with emphasis on the major role played by SBIs. In addition, we neutropenia occurred in around half of the study patients without any association with age 448 subgroups and severity of neutropenia. 

Isolation rates of Brucella melitensis in an endemic area 590 and implications for laboratory safety

Epidemiological, diagnostic, clinical, and therapeutic aspects of Brucella bacteremia 594 in children in southern Israel: a 7-year retrospective study

Murine typhus is a common cause of 597

The clinical significance of non-malignant neutropenia in 602 hospitalized children

Low risk of bacteremia in otherwise healthy 607 children presenting with fever and severe neutropenia

Risk of serious bacterial infection in isolated and 610

Infectious etiologies 612 of transient neutropenia in previously healthy children

Transient neutropenia in children with febrile illness and associated infectious 616 agents: 2 years follow-up

The epidemiology, clinical course and outcome of febrile cytopenia in children

Identification and clinical characterization of 633 children with benign ethnic neutropenia